Circulating tumor cells in immunohistochemical subtypes of metastatic breast cancer: lack of prediction in HER2-positive disease treated with targeted therapyAntonio Giordano, Massimo Cristofanilli, R. H. Alvarez et al.|Annals of Oncology|2011Cited by 102
Prognostic value of circulating tumor cells (CTC) in metastatic breast cancer (MBC): Correlation with immunohistochemically defined molecular subtypes and metastatic disease sites.Antonio Giordano, Massimo Cristofanilli, Mario Giuliano et al.|Journal of Clinical Oncology|2010Cited by 10
Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line therapy.Mario Giuliano, Massimo Cristofanilli, Antonio Giordano et al.|Journal of Clinical Oncology|2010Cited by 4
Circulating tumor cells as a prognostic factor independent of obesity in metastatic breast cancer patients.Mario Giuliano, James M. Reuben, Antonio Giordano et al.|Journal of Clinical Oncology|2011Cited by 1